BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie HW, Wu QQ, Zhu B, Chen FJ, Ji L, Li SQ, Wang CM, Tong YS, Tuo L, Wu M. Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumour Biol. 2014;35:7743-7754. [PMID: 24810925 DOI: 10.1007/s13277-014-2013-y] [Cited by in Crossref: 67] [Cited by in F6Publishing: 77] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Liu C, Lu Z, Chen L, Wang J, Li Y, Ma H. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer. Biomedicine & Pharmacotherapy 2017;88:529-34. [DOI: 10.1016/j.biopha.2017.01.037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
2 Wu T, Du Y. LncRNAs: From Basic Research to Medical Application. Int J Biol Sci 2017;13:295-307. [PMID: 28367094 DOI: 10.7150/ijbs.16968] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
3 Roth A, Diederichs S. Long Noncoding RNAs in Lung Cancer. Curr Top Microbiol Immunol 2016;394:57-110. [PMID: 26037047 DOI: 10.1007/82_2015_444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
4 Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget 2017;8:3104-10. [PMID: 27902971 DOI: 10.18632/oncotarget.13621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Qian P, Xu Z, Chen H, Yue S, Lv Y. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis. J Genet 2020;99. [DOI: 10.1007/s12041-020-01203-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang C, Li R, Qi Y, Li X, Yang Y, Liu D, Zhao J, Zhu D, Wu K, Zhou X, Zhao S. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial–mesenchymal transition. Cell Biol Toxicol 2016;32:391-401. [DOI: 10.1007/s10565-016-9341-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
7 Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao XG, Hu HY. BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients. Onco Targets Ther 2016;9:2221-6. [PMID: 27143917 DOI: 10.2147/OTT.S99401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhuang J, Lu Q, Shen B, Huang X, Shen L, Zheng X, Huang R, Yan J, Guo H. TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci Rep 2015;5:11924. [PMID: 26152796 DOI: 10.1038/srep11924] [Cited by in Crossref: 131] [Cited by in F6Publishing: 138] [Article Influence: 18.7] [Reference Citation Analysis]
9 Yang Y, Sun X, Chi C, Liu Y, Lin C, Xie D, Shen X, Lin X. Upregulation of long noncoding RNA LINC00152 promotes proliferation and metastasis of esophageal squamous cell carcinoma. Cancer Manag Res 2019;11:4643-54. [PMID: 31191025 DOI: 10.2147/CMAR.S198905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
10 Hulstaert E, Brochez L, Volders PJ, Vandesompele J, Mestdagh P. Long non-coding RNAs in cutaneous melanoma: clinical perspectives. Oncotarget 2017;8:43470-80. [PMID: 28415644 DOI: 10.18632/oncotarget.16478] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
11 Zhang H, Yang F, Chen S, Che J, Zheng J. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumor Biol 2015;36:2947-55. [DOI: 10.1007/s13277-014-2925-6] [Cited by in Crossref: 131] [Cited by in F6Publishing: 147] [Article Influence: 16.4] [Reference Citation Analysis]
12 Yang W, Han Y, Zhao X, Duan L, Zhou W, Wang X, Shi G, Che Y, Zhang Y, Liu J, Zhang H, Zhao Q, Hong L, Fan D. Advances in prognostic biomarkers for esophageal cancer. Expert Review of Molecular Diagnostics 2019;19:109-19. [DOI: 10.1080/14737159.2019.1563485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nasrollahzadeh-Khakiani M, Emadi-Baygi M, Schulz WA, Nikpour P. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis. Brief Funct Genomics 2017;16:129-45. [PMID: 27122631 DOI: 10.1093/bfgp/elw011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
14 Luo P, Jing W, Zhu M, Li ND, Zhou H, Yu MX, Liang CZ, Tu JC. Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance. Cancer Biomark. 2017;18:285-290. [PMID: 28085012 DOI: 10.3233/cbm-160305] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
15 Shen WJ, Zhang F, Zhao X, Xu J. LncRNAs and Esophageal Squamous Cell Carcinoma - Implications for Pathogenesis and Drug Development. J Cancer 2016;7:1258-64. [PMID: 27390601 DOI: 10.7150/jca.14869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wang M, Dong X, Feng Y, Sun H, Shan N, Lu T. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis. Oncotarget 2017;8:33713-24. [PMID: 28410241 DOI: 10.18632/oncotarget.16735] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
17 Wu H, Wang Y, Chen T, Li Y, Wang H, Zhang L, Chen S, Wang W, Yang Q, Chen C. The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1. Biosci Rep 2018;38:BSR20180411. [PMID: 30104400 DOI: 10.1042/BSR20180411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 He XJ, Bian EB, Ma CC, Wang C, Wang HL, Zhao B. Long non-coding RNA SPRY4-IT1 promotes the proliferation and invasion of U251 cells through upregulation of SKA2. Oncol Lett 2018;15:3977-84. [PMID: 29467908 DOI: 10.3892/ol.2018.7776] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Tan W, Song ZZ, Xu Q, Qu X, Li Z, Wang Y, Yu Q, Wang S. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer. Med Sci Monit 2017;23:309-14. [PMID: 28099409 DOI: 10.12659/msm.898369] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
20 Shi Y, Li J, Liu Y, Ding J, Fan Y, Tian Y, Wang L, Lian Y, Wang K, Shu Y. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression. Mol Cancer 2015;14:51. [PMID: 25742952 DOI: 10.1186/s12943-015-0318-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 13.0] [Reference Citation Analysis]
21 Wang W, Zhu Y, Li S, Chen X, Jiang G, Shen Z, Qiao Y, Wang L, Zheng P, Zhang Y. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2. Oncotarget 2016;7:25668-82. [PMID: 27015363 DOI: 10.18632/oncotarget.8257] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 14.3] [Reference Citation Analysis]
22 Li J, Chen Y, Chen Z, He A, Xie H, Zhang Q, Cai Z, Liu Y, Huang W. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers. Tumour Biol 2017;39:101042831771140. [DOI: 10.1177/1010428317711406] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
23 Heery R, Finn SP, Cuffe S, Gray SG. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel). 2017;9. [PMID: 28430163 DOI: 10.3390/cancers9040038] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 17.6] [Reference Citation Analysis]
24 Hu Z, Wu H, Li Y, Hou Q, Wang Y, Li S, Xia B, Wu S. β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expression. Anticancer Drugs 2015;26:531-9. [PMID: 25646744 DOI: 10.1097/CAD.0000000000000216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
25 Yao W, Bai Y, Li Y, Guo L, Zeng P, Wang Y, Qi B, Liu S, Qin X, Li Y, Zhao B. Upregulation of MALAT-1 and its association with survival rate and the effect on cell cycle and migration in patients with esophageal squamous cell carcinoma. Tumor Biol 2016;37:4305-12. [DOI: 10.1007/s13277-015-4223-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
26 Zhang D, Hou XL, Wu B, Li DD. Long non-coding RNAs in esophageal cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(17): 2744-2753 [DOI: 10.11569/wcjd.v23.i17.2744] [Reference Citation Analysis]
27 Peng Q, Wang J. Non-coding RNAs in melanoma: Biological functions and potential clinical applications. Mol Ther Oncolytics 2021;22:219-31. [PMID: 34514101 DOI: 10.1016/j.omto.2021.05.012] [Reference Citation Analysis]
28 Cao S, Lin L, Xia X, Wu H. lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer. Mol Ther Nucleic Acids 2019;17:455-64. [PMID: 31330497 DOI: 10.1016/j.omtn.2019.04.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
29 Li Z, Shen J, Chan MTV, Wu WKK. The long non-coding RNA SPRY4-IT1: An emerging player in tumorigenesis and osteosarcoma. Cell Prolif 2018;51:e12446. [PMID: 29484753 DOI: 10.1111/cpr.12446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
30 Gutschner T, Richtig G, Haemmerle M, Pichler M. From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer. Cancer Metastasis Rev 2018;37:83-105. [PMID: 29247341 DOI: 10.1007/s10555-017-9718-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
31 Tang WW, Wu Q, Li SQ, Tong YS, Liu ZH, Yang TX, Xu Y, Cao XF. Implication of lncRNAs in pathogenesis of esophageal cancer. Onco Targets Ther 2015;8:3219-26. [PMID: 26609239 DOI: 10.2147/OTT.S87856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
32 Ghafouri‐fard S, Shoorei H, Dashti S, Branicki W, Taheri M. Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response. J Cell Physiol 2020;235:9269-90. [DOI: 10.1002/jcp.29825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R. LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1. Onco Targets Ther 2018;11:639-49. [PMID: 29430188 DOI: 10.2147/OTT.S157638] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
34 Li JK, Chen C, Liu JY, Shi JZ, Liu SP, Liu B, Wu DS, Fang ZY, Bao Y, Jiang MM, Yuan JH, Qu L, Wang LH. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer 2017;16:111. [PMID: 28659173 DOI: 10.1186/s12943-017-0681-0] [Cited by in Crossref: 117] [Cited by in F6Publishing: 131] [Article Influence: 23.4] [Reference Citation Analysis]
35 Peng W, Wu G, Fan H, Wu J, Feng J. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Tumour Biol. 2015;Epub ahead of print. [PMID: 25835973 DOI: 10.1007/s12035-015-9142-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
36 Ma W, Chen X, Wu X, Li J, Mei C, Jing W, Teng L, Tu H, Jiang X, Wang G, Chen Y, Wang K, Wang H, Wei Y, Liu Z, Yuan Y. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway. J Cell Physiol. 2020;. [PMID: 31943198 DOI: 10.1002/jcp.29438] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
37 Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y, Yang K. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2015;34:7. [PMID: 25613496 DOI: 10.1186/s13046-015-0123-z] [Cited by in Crossref: 137] [Cited by in F6Publishing: 149] [Article Influence: 19.6] [Reference Citation Analysis]
38 Liu T, Shen SK, Xiong JG, Xu Y, Zhang HQ, Liu HJ, Lu ZG. Clinical significance of long noncoding RNA SPRY4-IT1 in melanoma patients. FEBS Open Bio 2016;6:147-54. [PMID: 27239436 DOI: 10.1002/2211-5463.12030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
39 Qie P, Yin Q, Xun X, Song Y, Zhou S, Liu H, Feng J, Tian Z. Long non-coding RNA SPRY4-IT1 as a promising indicator for three field lymph-node dissection of thoracic esophageal carcinoma. J Cardiothorac Surg 2021;16:48. [PMID: 33757566 DOI: 10.1186/s13019-021-01433-x] [Reference Citation Analysis]
40 Shi WH, Wu QQ, Li SQ, Yang TX, Liu ZH, Tong YS, Tuo L, Wang S, Cao XF. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma. Tumour Biol 2015;36:2501-7. [PMID: 25731728 DOI: 10.1007/s13277-014-2863-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 8.7] [Reference Citation Analysis]
41 Deng HY, Wang YC, Ni PZ, Lin YD, Chen LQ. Long noncoding RNAs are novel potential prognostic biomarkers for esophageal squamous cell carcinoma: an overview. J Thorac Dis. 2016;8:E653-E659. [PMID: 27621894 DOI: 10.21037/jtd.2016.07.01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
42 Cao D, Ding Q, Yu W, Gao M, Wang Y. Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial-mesenchymal transition. Onco Targets Ther. 2016;9:5417-5425. [PMID: 27621655 DOI: 10.2147/ott.s111794] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
43 Lin CY, Xu HM. Novel perspectives of long non-coding RNAs in esophageal carcinoma. Carcinogenesis 2015;36:1255-62. [PMID: 26392258 DOI: 10.1093/carcin/bgv136] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
44 Lee B, Sahoo A, Marchica J, Holzhauser E, Chen X, Li JL, Seki T, Govindarajan SS, Markey FB, Batish M, Lokhande SJ, Zhang S, Ray A, Perera RJ. The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules. Sci Adv 2017;3:e1602505. [PMID: 28508063 DOI: 10.1126/sciadv.1602505] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
45 Li N, Tan Q, Jing W, Luo P, Tu J. Long Non-Coding RNA SPRY4-IT1 Can Predict Unfavorable Prognosis and Lymph Node Metastasis: a Meta-Analysis. Pathol Oncol Res 2017;23:731-6. [DOI: 10.1007/s12253-016-0182-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Guo W, Dong Z, Shi Y, Liu S, Liang J, Guo Y, Guo X, Shen S, Shan B. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. Dig Liver Dis 2016;48:961-9. [PMID: 27338851 DOI: 10.1016/j.dld.2016.05.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
47 Zhang Y, Jin X, Wang Z, Zhang X, Liu S, Liu G. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer. Cancer Biomark 2017;21:89-96. [PMID: 29081407 DOI: 10.3233/CBM-170286] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
48 Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ, Cao XF. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14:3. [PMID: 25608466 DOI: 10.1186/1476-4598-14-3] [Cited by in Crossref: 197] [Cited by in F6Publishing: 199] [Article Influence: 28.1] [Reference Citation Analysis]
49 Ye Y, Gu J, Liu P, Wang H, Jiang L, Lei T, Yu S, Han G, Wang Z. Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC. Onco Targets Ther 2020;13:2783-93. [PMID: 32308413 DOI: 10.2147/OTT.S232769] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
50 Wang HM, Li HJ, Chen JZ, Pei K, Zhang Q, Liu ZD, Qi YF. Prognostic Value of Long Noncoding RNA SPRY4-IT1 on Survival Outcomes in Human Carcinomas: A Systematic Review and Meta-Analysis with TCGA Database. Biomed Res Int 2020;2020:5868602. [PMID: 33204703 DOI: 10.1155/2020/5868602] [Reference Citation Analysis]
51 Cao Y, Liu Y, Lu X, Wang Y, Qiao H, Liu M. Upregulation of long noncoding RNA SPRY4-IT1 correlates with tumor progression and poor prognosis in cervical cancer. FEBS Open Bio 2016;6:954-60. [PMID: 27642559 DOI: 10.1002/2211-5463.12102] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
52 Sun C, Ding Y, Wang S, Hu W. Long Non-Coding RNA SPRY4-IT1 Can Predict Poor Prognosis in Digestive System Malignancies: a Meta-Analysis. Pathol Oncol Res 2019;25:89-95. [PMID: 28965279 DOI: 10.1007/s12253-017-0327-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
53 Luo D, Huang Z, Lv H, Wang Y, Sun W, Sun X. Up-Regulation of MicroRNA-21 Indicates Poor Prognosis and Promotes Cell Proliferation in Esophageal Squamous Cell Carcinoma via Upregulation of lncRNA SNHG1. Cancer Manag Res 2020;12:1-14. [PMID: 32021418 DOI: 10.2147/CMAR.S221731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Fanelli GN, Gasparini P, Coati I, Cui R, Pakula H, Chowdhury B, Valeri N, Loupakis F, Kupcinskas J, Cappellesso R, Fassan M. LONG-NONCODING RNAs in gastroesophageal cancers. Noncoding RNA Res 2018;3:195-212. [PMID: 30533569 DOI: 10.1016/j.ncrna.2018.10.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
55 Zhao H, De Souza C, Kumar VE, Nambiar R, Hao D, Zhu X, Luo Y, Liu S, Zhang L, Zhu J. Long non-coding RNA signatures as predictors of prognosis in thyroid cancer: a narrative review. Ann Transl Med 2021;9:359. [PMID: 33708986 DOI: 10.21037/atm-20-8191] [Reference Citation Analysis]
56 Kladi-Skandali A, Michaelidou K, Scorilas A, Mavridis K. Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? Gastroenterol Res Pract 2015;2015:319861. [PMID: 26064090 DOI: 10.1155/2015/319861] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
57 Zhang S, Li J, Gao H, Tong Y, Li P, Wang Y, Du L, Wang C. lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:656554. [PMID: 34127945 DOI: 10.3389/fcell.2021.656554] [Reference Citation Analysis]
58 Sharma U, Murmu M, Barwal TS, Tuli HS, Jain M, Prakash H, Kaceli T, Jain A, Bishayee A. A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response. Current Oncology 2022;29:2326-49. [DOI: 10.3390/curroncol29040189] [Reference Citation Analysis]
59 Yang Y, Ma B, Yan Y, Song Y, Gao P, Sun J, Wang J, Wang Z. Long non-coding RNA HOXA transcript at the distal tip as a biomarker for gastric cancer. Oncol Lett 2017;14:1068-72. [PMID: 28693275 DOI: 10.3892/ol.2017.6186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
60 Su M, Xiao Y, Ma J, Cao D, Zhou Y, Wang H, Liao Q, Wang W. Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications. J Hematol Oncol 2018;11:118. [PMID: 30223861 DOI: 10.1186/s13045-018-0663-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
61 Xie M, Nie FQ, Sun M, Xia R, Liu YW, Zhou P, De W, Liu XH. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. J Transl Med. 2015;13:250. [PMID: 26238992 DOI: 10.1186/s12967-015-0595-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
62 Zhou XL, Wang WW, Zhu WG, Yu CH, Tao GZ, Wu QQ, Song YQ, Pan P, Tong YS. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Mol Carcinog 2016;55:2095-105. [PMID: 26756568 DOI: 10.1002/mc.22454] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 9.0] [Reference Citation Analysis]
63 Zhong Y, Chen Z, Guo S, Liao X, Xie H, Zheng Y, Cai B, Huang P, Liu Y, Zhou Q, Liu Y, Huang W. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2017;96:e8583. [PMID: 29145271 DOI: 10.1097/MD.0000000000008583] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
64 Peng W, Wu G, Fan H, Wu J, Feng J. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Tumour Biol. 2015;36:6751-6758. [PMID: 25835973 DOI: 10.1007/s13277-015-3376-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 7.7] [Reference Citation Analysis]
65 Gong T, Zheng S, Huang S, Fu S, Zhang X, Pan S, Yang T, Sun Y, Wang Y, Hui B, Guo J, Zhang X. PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis. Mol Carcinog 2017;56:2610-9. [PMID: 28731203 DOI: 10.1002/mc.22705] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
66 Tong H, Liu Y, Jiang L, Wang J. Multi-Targeting by β-Elemene and Its Anticancer Properties: A Good Choice for Oncotherapy and Radiochemotherapy Sensitization. Nutr Cancer 2020;72:554-67. [PMID: 31387393 DOI: 10.1080/01635581.2019.1648694] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Zheng X, Hu H, Li S. High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett 2016;12:2357-62. [PMID: 27698800 DOI: 10.3892/ol.2016.5026] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 8.3] [Reference Citation Analysis]
68 Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X, Wang M, Huang C, Wang L, Zeng F, Jiang G. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. Cancer Lett 2017;388:281-91. [PMID: 27998761 DOI: 10.1016/j.canlet.2016.12.005] [Cited by in Crossref: 137] [Cited by in F6Publishing: 156] [Article Influence: 22.8] [Reference Citation Analysis]
69 Jiang C, Li X, Zhao H, Liu H. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer 2016;15:62. [PMID: 27686732 DOI: 10.1186/s12943-016-0545-z] [Cited by in Crossref: 104] [Cited by in F6Publishing: 109] [Article Influence: 17.3] [Reference Citation Analysis]
70 Ding X, Qi C, Min J, Xu Z, Huang K, Tang H. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma. J Cell Mol Med 2020;24:10551-9. [PMID: 32729661 DOI: 10.1111/jcmm.15673] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Ghaffar M, Khodahemmati S, Li J, Shahzad M, Wang M, Wang Y, Li C, Chen S, Zeng Y. Long Non-coding RNA LINC01234 Regulates Proliferation, Invasion and Apoptosis in Esophageal Cancer Cells. J Cancer 2018;9:4242-9. [PMID: 30519325 DOI: 10.7150/jca.26095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
72 Alaei S, Sadeghi B, Najafi A, Masoudi-Nejad A. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma. Genomics 2019;111:76-89. [PMID: 29317304 DOI: 10.1016/j.ygeno.2018.01.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
73 Kang W, Zheng Q, Lei J, Chen C, Yu C. Prognostic Value of Long Noncoding RNAs in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis. Dis Markers 2018;2018:5340894. [PMID: 30598708 DOI: 10.1155/2018/5340894] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
74 Peng Z, Zhang C, Duan C. Functions and mechanisms of long noncoding RNAs in lung cancer. Onco Targets Ther 2016;9:4411-24. [PMID: 27499635 DOI: 10.2147/OTT.S109549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
75 Guo W, Zhong K, Wei H, Nie C, Yuan Z. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells. PLoS One 2018;13:e0193483. [PMID: 29489909 DOI: 10.1371/journal.pone.0193483] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
76 Xue W, Zheng Y, Shen Z, Li L, Fan Z, Wang W, Zhu Z, Zhai Y, Zhao J, Kan Q. Involvement of long non-coding RNAs in the progression of esophageal cancer. Cancer Commun (Lond) 2021;41:371-88. [PMID: 33605567 DOI: 10.1002/cac2.12146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Sugihara H, Ishimoto T, Miyake K, Izumi D, Baba Y, Yoshida N, Watanabe M, Baba H. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma. Int J Mol Sci. 2015;16:27824-27834. [PMID: 26610479 DOI: 10.3390/ijms161126060] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
78 Sadeghpour S, Ghorbian S. Evaluation of the potential clinical prognostic value of lncRNA-BANCR gene in esophageal squamous cell carcinoma. Mol Biol Rep 2019;46:991-5. [PMID: 30552615 DOI: 10.1007/s11033-018-4556-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]